SCHEMBL8675010

SCHEMBL8675010

CC(=O)OCC1CCCC1COC(C)=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.40
LMNA P02545 1/20 0.40
HSD17B10 Q99714 1/20 0.40
NLRP3 Q96P20 2/20 0.37
CHRM1 P11229 3/20 0.36
CHRM2 P08172 2/20 0.36
CHRM4 P08173 2/20 0.36
CHRM3 P20309 2/20 0.36
PDK1 Q15118 1/20 0.33
PGR P06401 1/20 0.33
HTR1A P08908 1/20 0.33
CHRM5 P08912 1/20 0.33
CHRNB2 P17787 1/20 0.33
TBXA2R P21731 1/20 0.33
CHRNB4 P30926 1/20 0.33
CHRNA3 P32297 1/20 0.33
CHRNA7 P36544 1/20 0.33
CHRNA4 P43681 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CHRNA10 Q9GZZ6 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8444773 0.95 ALDH1A1 (0.40) ALDH1A1LMNAHSD17B10NLRP3CHRM1
SCHEMBL8444777 0.95 ALDH1A1 (0.40) ALDH1A1LMNAHSD17B10NLRP3CHRM1
SCHEMBL8674653 0.93 ALDH1A1 (0.39) ALDH1A1LMNAHSD17B10NLRP3
SCHEMBL8674650 0.93 ALDH1A1 (0.39) ALDH1A1LMNAHSD17B10NLRP3
SCHEMBL2997498 0.93 ALDH1A1 (0.39) ALDH1A1LMNAHSD17B10NLRP3
SCHEMBL15615426 0.92 ALDH1A1 (0.34) ALDH1A1LMNAHSD17B10NLRP3CHRM1
SCHEMBL24912279 0.90 ALDH1A1 (0.43) ALDH1A1LMNAHSD17B10NLRP3CHRM1
SCHEMBL17550206 0.90 ALDH1A1 (0.43) ALDH1A1LMNAHSD17B10NLRP3CHRM1
SCHEMBL23785663 0.87 ALDH1A1 (0.34) ALDH1A1LMNAHSD17B10NLRP3CHRM1
SCHEMBL21019789 0.86 CHRM1 (0.33) ALDH1A1LMNAHSD17B10NLRP3CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5783602-A Leukotriene-B4 derivatives, process for their production and their use as pharmaceutical agents SCHERING AKTIENGESELLSCHAFT (DE) 1998-07-21 US disclosed